Bellevue Medtech & Services I

Dati di base

ISIN LU0415391787
Numero di valore
Bloomberg Global ID
Nome del fondo Bellevue Medtech & Services I
Offerente del fondo Bellevue Asset Management AG Zürich, Svizzera
Telefono: +41 44 267 67 00
E-Mail: info@bellevue.ch
Web: www.bellevue.ch
Offerente del fondo Bellevue Asset Management AG
Rappresentante in Svizzera Waystone Fund Services (Switzerland) SA
Lausanne
Telefono: 0041213111781
Distributore(i) Bank am Bellevue AG
Küsnacht
Telefono: +41 44 267 67 67
Asset class Fondi azionari
EFC Categoria
Classe di quote Accumulation
Paese di domicilio Lussemburgo
Condizioni all-unknown-emissione Combinazione di commissione di emissione a favore della direzione del fondo e commissione di transazione a favore del fondo
Condizioni al riscatto Combinazione di commissione di riscatto a favore della direzione del fondo e commissione di transazione a favore del fondo
Strategia d'investimenti *** The sub-fund is an equity fund. The investment objective of the sub-fund is to achieve long-term capital growth by investing at least two-thirds of the net assets of the sub-fund in a portfolio of carefully chosen shares and other equity securities of companies in the medical technology industry or companies whose main activity involves holding investments in such companies or financing such companies and that have their registered office or carry out the majority of their economic activity in recognised countries. Without restricting the scope of the term “medtech and services”, companies in the medtech and services sector consist of companies primarily engaged in the production, development, funding, marketing and sale of medical devices and the provision of technical medical services, such as hospitals and laboratories, or the facilitation of processes relevant to these facilities; as well as entities primarily engaged in investing in or financing such companies.
Particolarità

Prezzi del fondo

Prezzo attuale * 499.33 CHF 30.10.2024
Prezzo precedente * 500.19 CHF 29.10.2024
Max 52 settimani * 514.56 CHF 27.03.2024
Min 52 settimani * 402.75 CHF 09.11.2023
NAV * 499.33 CHF 30.10.2024
Issue Price *
Redemption Price *
Closing Price *
Prezzo minimo indicativo
Attivo del fondo *** 1'461'027'542
Attivo della classe ***
Trading Information SIX

Performance

Performance YTD +14.50% 29.12.2023
30.10.2024
1 mese +0.84% 30.09.2024
30.10.2024
3 mesi +3.90% 30.07.2024
30.10.2024
6 mesi +1.81% 30.04.2024
30.10.2024
1 anno +26.20% 30.10.2023
30.10.2024
2 anni +4.74% 31.10.2022
30.10.2024
3 anni -7.46% 02.11.2021
30.10.2024
5 anni +3.06% 15.06.2021
30.10.2024

Dati fiscali

Quota di partecipazione al capitale in %
Utile totale del fondo in %
Quota immobiliare in %
ADDI
ADDI Date

10 posizioni principali ***

Boston Scientific Corp 9.83%
Intuitive Surgical Inc 9.79%
Abbott Laboratories 9.63%
Stryker Corp 8.91%
Medtronic PLC 4.88%
Becton Dickinson & Co 4.66%
Essilorluxottica 3.98%
Alcon Inc 3.88%
Edwards Lifesciences Corp 3.26%
GE HealthCare Technologies Inc Common Stock 2.53%
Ultimo aggiornamento dei dati 31.08.2024

Costi / Rischi

TER 1.53%
Data TER 29.01.2021
Performance Fee ***
PTR
Max. Management Fee *** 0.90%
Ongoing Charges *** 1.49%
SRRI ***
Data SRRI *** 30.09.2024

ESG Fund Ratings

Low Carbon Designation ***
ESG Rating Overall ***
ESG Rating Corporate ***
ESG Rating Sovereign ***
% AuM H&S Controversies ***

Breakdowns

Countries ***

Stock Sectors ***

Bond Sectors ***

ESG Carbon Metrics

Avg Carbon Risk Score ***
Avg Carbon Risk Cat Avg ***
% AuM Covered Carbon ***
Avg Fossil Fuel Exposure ***
Fossil Fuel Cat Avg ***

ESG Strategy

Strategy Level 1 ***
Strategy Level 2 ***
Strategy Level 3 ***
Exclusions Level 1 ***
Exclusions Level 2 ***

* NAV / Issue Price commissioni escluse, per fondi quotati in borsa NAV o quotazione di chiusura
** La calculazione del utile intermedio era fatto via § 9 Satz 2 InvStG
*** Sorgente dati: Morningstar (I dati si basano sulla posizione lunga riscalata delle partecipazioni)